| 1. | kingsnymptonps | |
| 2. | ghueck | |
| 3. | ccaseyrn7 | |
| 4. | jadeone11 | |
| 5. | benjimichigan |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | ccaseyrn7 01/25/2018 They get cash to work on their other targets |
| 2. | kingsnymptonps 01/25/2018 Heading North. |
| 3. | ghueck 03/15/2018 Misses EPS loss estimates by $0.15. Beats on revenues. |
| 4. | ccaseyrn7 01/25/2018 ah huh. |
| 5. | jadeone11 01/26/2018 Any problems here? |
| 6. | gojeck 01/25/2018 Awesome news! |
| 7. | jadeone11 08/07/2018 Beats EPS loss estimates by $0.21 and beats on revenues |
| 8. | kingsnymptonps 01/25/2018 $KPTI NEWS! Big money! |
| 9. | ghueck 01/26/2018 Been 2 good days now an offering |
| 10. | benjimichigan 05/24/2018 Karyopharm and Antengene Sign Exclusive License Agreement to Develop and Commercialize Selinexor, Eltanexor, Verdinexor and KPT-9274 in China and Other Regions in Asia |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Karyopharm Therapeutics Inc.
- KPTI
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.